Profile data is unavailable for this security.
About the company
CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
- Revenue in JPY (TTM)199.47m
- Net income in JPY-957.04m
- Incorporated2001
- Employees35.00
- LocationCellSeed Inc15FTelecom Center East Bldg., 2-5-10, AomiKOTO-KU 135-0064JapanJPN
- Phone+81 363807490
- Fax+81 363807491
- Websitehttps://www.cellseed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RaQualia Pharma Inc | 2.30bn | -673.00m | 10.08bn | 67.00 | -- | 1.79 | -- | 4.39 | -31.12 | -31.12 | 106.28 | 261.02 | 0.2652 | 3.82 | 2.89 | 34,300,980.00 | -7.77 | 2.13 | -8.56 | 2.26 | 84.78 | 88.49 | -29.28 | 5.32 | 3.55 | -- | 0.3972 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| ReproCell Inc | 2.60bn | -196.44m | 10.94bn | 96.00 | -- | 1.25 | -- | 4.21 | -2.21 | -2.21 | 29.29 | 92.79 | 0.2916 | 5.05 | 7.43 | 27,084,280.00 | -2.20 | -7.35 | -2.37 | -8.00 | 51.10 | 39.83 | -7.55 | -27.16 | 8.97 | -- | 0.00 | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| Symbio Pharmaceuticals Ltd | 3.07bn | -4.02bn | 11.11bn | 109.00 | -- | 2.15 | -- | 3.62 | -92.13 | -92.13 | 70.03 | 112.55 | 0.4225 | 2.97 | 4.47 | 28,137,370.00 | -55.36 | -19.18 | -62.58 | -23.62 | 77.57 | 65.84 | -131.05 | -24.32 | 6.51 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Ohki Healthcare Holdings Co Ltd | 342.45bn | 1.87bn | 12.00bn | 632.00 | 6.26 | 0.3897 | 5.48 | 0.035 | 136.22 | 136.22 | 24,995.05 | 2,189.15 | 2.45 | 12.90 | 4.52 | 541,849,700.00 | 1.29 | 1.85 | 5.54 | 8.42 | 5.00 | 6.16 | 0.5268 | 0.7178 | 0.8641 | -- | 0.2547 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Oncolys Biopharma Inc | 31.38m | -1.91bn | 15.88bn | 34.00 | -- | 7.36 | -- | 505.85 | -94.41 | -94.41 | 1.53 | 86.36 | 0.015 | 0.00 | 0.2917 | 923,058.80 | -91.65 | -45.75 | -104.28 | -51.86 | 0.00 | 60.46 | -6,093.40 | -233.66 | 9.72 | -102.93 | 0.1442 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.31bn | 16.25bn | 11.00 | -- | 5.07 | -- | -- | -72.79 | -72.79 | 0.00 | 167.60 | 0.00 | -- | -- | 0.00 | -38.05 | -62.25 | -42.35 | -70.91 | -- | -- | -- | -2,015.62 | -- | -- | -- | -- | -- | -- | 2.77 | -- | -- | -- |
| Stella Pharma Corp | 284.89m | -726.61m | 16.88bn | 44.00 | -- | 5.48 | -- | 59.25 | -22.94 | -22.94 | 8.91 | 90.49 | 0.061 | 0.0433 | 2.59 | 6,474,773.00 | -15.55 | -22.50 | -16.34 | -24.83 | 84.75 | -- | -255.05 | -488.65 | 17.82 | -563.58 | 0.217 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.28bn | -2.34bn | 18.38bn | 208.00 | -- | 2.26 | -- | 2.93 | -46.93 | -46.93 | 125.40 | 160.66 | 0.434 | 1.69 | 2.94 | 30,201,920.00 | -16.12 | -- | -19.68 | -- | 55.73 | -- | -37.15 | -- | 2.83 | -- | 0.2166 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 19.58bn | 35.00 | -- | 8.93 | -- | 98.16 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Astena Holdings Co Ltd | 53.39bn | 2.09bn | 20.25bn | 1.40k | 9.39 | 0.6851 | 4.40 | 0.3792 | 52.62 | 52.62 | 1,341.82 | 721.11 | 0.7976 | 3.29 | 2.69 | 38,024,920.00 | 3.12 | 2.49 | 5.76 | 4.44 | 34.11 | 25.33 | 3.91 | 2.32 | 0.879 | 391.65 | 0.349 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.96bn | 44.00 | -- | 2.47 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | 0.00 | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 57.72bn | 2.20bn | 24.64bn | 1.31k | 10.13 | 0.5876 | 5.50 | 0.4269 | 257.39 | 257.39 | 6,774.96 | 4,436.49 | 0.7581 | 3.07 | 2.33 | 44,163,730.00 | 2.89 | 1.91 | 4.97 | 3.09 | 26.58 | 26.92 | 3.81 | 2.69 | 0.9406 | 50.75 | 0.267 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
Data as of Nov 22 2024. Currency figures normalised to CellSeed Inc's reporting currency: Japanese Yen JPY
0.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 196.70k | 0.57% |
Data from 14 Nov 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
